News | Balloon Catheter | January 24, 2018

Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions

Company partners with OrbusNeich as exclusive U.S. distributor of peripheral and coronary balloons, announces OEM agreement for CSI-branded Zilient guidewires

Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions

January 24, 2018 — Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is now the exclusive U.S. distributor of OrbusNeich balloon catheter products. Additionally, the company has signed an original equipment manufacturer (OEM) agreement with Integer Holdings Corp. for CSI-branded Zilient guidewires.

OrbusNeich has established balloon technologies in both percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) outside the United States. As the exclusive distributor of OrbusNeich balloon products in the United States, CSI will ultimately offer their full line of semi-compliant, non-compliant and specialty balloons for both coronary and peripheral vascular procedures. OrbusNeich PCI balloons include the Sapphire II Pro, which is currently on schedule this year to obtain U.S. Food and Drug Administration (FDA) clearance for what it calls the first and only 1mm coronary balloon to be available in the United States. Currently, CSI offers both the 1.5-4mm Sapphire II Pro and the 2-4mm Sapphire NC Plus coronary balloons. The company anticipates OrbusNeich’s full balloon product portfolio will become available throughout 2018 and 2019.

CSI has also contracted with Integer Holdings Corporation to produce CSI-branded Zilient guidewires. These guidewires are designed to provide tip resilience and crossability in challenging arterial lesions. CSI is currently offering guidewires to select accounts for use in peripheral interventions in the following sizes/configurations:

  • .014-inch diameter with 4, 6, 12 and 30 gram tip stiffness, 300 cm length; and
  • .018-inch diameter with 4, 6, 12 and 30 gram tip stiffness, 300 cm length

The broad market launch of the CSI-branded Zilient peripheral guidewires is expected to begin later in the current fiscal year. CSI anticipates that additional Zilient guidewires for coronary interventions and radial peripheral interventions will be available in the future.

For more information: www.csi360.com

 

Related Content

Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init